Key result
Radiotherapy for angiosarcoma achieves ~64% 5-year local control, favoring small nonscalp tumors.
Why the study?
What are the prognostic factors and outcomes for patients with angiosarcoma treated with radiotherapy?
Population
41 patients with angiosarcoma treated with radiotherapy between 1974 and 2009, median age 67 years.
Design
Cohort
Follow-up
median 3.7 years
Authors
Loading...
Prognostic factors after radiotherapy for angiosarcoma remain unclear; leaves open optimal multimodal strategies for prospective validation.
Cohort (n=41)
What are the prognostic factors and outcomes for patients with angiosarcoma treated with radiotherapy?
For angiosarcomas treated with radiotherapy, outcomes vary widely and are improved by smaller tumor size, nonscalp location, and combined-modality therapy.
Scott et al. (2012) conducted a cohort in Angiosarcoma (n=41). Radiotherapy was evaluated on 5-year local control and overall survival. Radiotherapy for angiosarcoma yielded 5-year local control and overall survival rates of 64% and 54%, with better outcomes for nonscalp tumors ≤5 cm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: